HKSE - Delayed Quote • HKD
Shandong Weigao Group Medical Polymer Company Limited (1066.HK)
At close: 4:08 PM GMT+8
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
13,438,018.000
13,619,007.000
13,208,942.000
11,622,337.000
Cost of Revenue
6,489,461.000
6,505,925.000
5,856,049.000
5,122,766.000
Gross Profit
6,948,557.000
7,113,082.000
7,352,893.000
6,499,571.000
Operating Expense
4,080,709.000
3,965,620.000
4,201,818.000
3,940,802.000
Operating Income
2,867,848.000
3,147,462.000
3,151,075.000
2,558,769.000
Net Non Operating Interest Income Expense
-77,709.000
-11,112.000
4,219.000
-63,956.000
Pretax Income
2,840,708.000
3,317,901.000
2,877,845.000
2,565,459.000
Tax Provision
368,609.000
424,267.000
420,066.000
358,422.000
Net Income Common Stockholders
2,398,943.000
2,723,309.000
2,275,929.000
2,086,783.000
Average Dilution Earnings
--
-862.000
-923.000
--
Diluted NI Available to Com Stockholders
2,398,081.000
2,722,447.000
2,275,006.000
2,086,783.000
Basic EPS
0.54
0.60
0.51
0.46
Diluted EPS
0.54
0.60
0.50
0.46
Basic Average Shares
4,508,996.959
4,505,556.000
4,500,994.000
4,489,196.000
Diluted Average Shares
--
4,526,649.000
4,516,323.000
4,492,953.000
Total Expenses
10,570,170.000
10,471,545.000
10,057,867.000
9,063,568.000
Net Income from Continuing & Discontinued Operation
2,398,943.000
2,723,309.000
2,275,929.000
2,086,783.000
Normalized Income
2,430,932.169
2,768,758.201
2,560,068.850
2,028,401.185
Interest Income
--
180,289.000
144,660.000
114,979.000
Interest Expense
257,998.000
191,401.000
140,441.000
178,935.000
Net Interest Income
-77,709.000
-11,112.000
4,219.000
-63,956.000
EBIT
3,098,706.000
3,509,302.000
3,018,286.000
2,744,394.000
EBITDA
3,098,706.000
4,311,814.000
3,754,956.000
3,453,355.000
Reconciled Cost of Revenue
6,489,461.000
6,505,925.000
5,856,049.000
5,122,766.000
Reconciled Depreciation
--
802,512.000
736,670.000
708,961.000
Net Income from Continuing Operation Net Minority Interest
2,398,943.000
2,723,309.000
2,275,929.000
2,086,783.000
Total Unusual Items Excluding Goodwill
-36,759.000
-52,113.000
-332,703.000
67,863.000
Total Unusual Items
-36,759.000
-52,113.000
-332,703.000
67,863.000
Normalized EBITDA
3,135,465.000
4,363,927.000
4,087,659.000
3,385,492.000
Tax Rate for Calcs
0.000
0.000
0.000
0.000
Tax Effect of Unusual Items
-4,769.831
-6,663.799
-48,563.150
9,481.185
12/31/2020 - 2/27/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade